Company Filing History:
4 out of 3,539 
2 out of 1,217 
1 out of 28 
Years Active: 1995-2006
Title: Errol Reiss: Innovator in Nucleic Acid Detection
Introduction
Errol Reiss is a notable inventor based in Chamblee, GA (US), recognized for his contributions to the field of molecular biology. He holds a total of 11 patents, showcasing his innovative approach to detecting various fungal species through nucleic acids.
Latest Patents
Among his latest patents, Reiss has developed nucleic acids for detecting Fusarium species and other filamentous fungi. These innovations include unique internal transcribed spacer 2 coding regions that allow for the creation of nucleic acid probes specific to multiple species. His work also encompasses methods for species-specific detection and diagnosis of infections in subjects. Additionally, he has provided nucleotide sequences for the M antigen gene, along with vectors and host expression systems that utilize these nucleic acids. His inventions further include antibodies generated against these antigens, along with methods and kits for diagnosing histoplasmosis.
Career Highlights
Reiss has had a distinguished career, working with prominent organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and The United States of America as represented by the Department of Health. His work in these institutions has significantly advanced the understanding and detection of fungal infections.
Collaborations
Throughout his career, Reiss has collaborated with esteemed colleagues, including Christine J Morrison and Timothy J Lott. These partnerships have contributed to the success and impact of his research and inventions.
Conclusion
Errol Reiss stands out as a significant figure in the field of molecular biology, with a focus on nucleic acid detection. His innovative patents and collaborations have made a lasting impact on the detection and diagnosis of fungal infections.